Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Our lead candidate, BIO 300 is being developed for multiple clinical uses with a primary focus on improving treatment of solid tumor cancers. BIO 300 is being developed as an agent to both sensitize tumor cells to enhance radiation treatment efficacy and to protect normal tissues from harm. Thus, reducing common treatment related side effects such as radiation induced pneumonitis, erectile dysfunction, mucositis and xerostomia. BIO 300 is also under development for inflammatory lung diseases with an immediate focus on mitigation of pulmonary injury due to COVID-19. A recent contract from NIAID will fund a phase 2 study on BIO 300 in recovering COVID patients in an effort to stem progressive long-term lung complications, such as fibrosis. BIO 300 was licensed from the US Department of Defense, where it was originally developed to prevent injuries associated with ionizing radiation. This program is still underway with a focus on prevention of acute radiation syndrome as well as lung injury. For more information about Humanetics, please visit our corporate website at www.humaneticscorp.com.
View Top Employees from Humanetics CorporationWebsite | http://www.humaneticscorp.com |
Revenue | $3 million |
Employees | 17 (9 on RocketReach) |
Founded | 1988 |
Address | 7760 France Avenue South Suite 920, Minneapolis, Minnesota 55435, US |
Phone | (952) 937-7660 |
Fax | (952) 937-7667 |
Technologies |
JavaScript,
HTML,
Google Analytics
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Clinical Trials, Pharmaceuticals, Manufacturing, Health Care, Consumer Products, Medical, Medical Foods, Pharmaceutical |
Web Rank | 17 Million |
Keywords | Humanetics, Zeljko Vujaskovic, Isabel Jackson Phd |
Competitors | Aclaris Therapeutics, Inc., KemPharm, Inc., PolyPid Ltd., Presidio Pharmaceuticals, Inc., TARIS Bio |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Humanetics Corporation employee's phone or email?
The Humanetics Corporation annual revenue was $3 million in 2024.
Ronald Zenk is the Chief Executive Officer and Director of Humanetics Corporation.
9 people are employed at Humanetics Corporation.
Humanetics Corporation is based in Minneapolis, Minnesota.
The NAICS codes for Humanetics Corporation are [33, 54171, 541711, 541, 5417, 54].
The SIC codes for Humanetics Corporation are [384, 38].